深度学习模型鉴别多发性硬化与MOG抗体相关疾病
该多中心回顾性横断面研究纳入406例成人MRI扫描,评估临床/MRI算法并开发深度学习模型区分RRMS与MOGAD。联合分类器达86%准确率、84%敏感性和89%特异性,概率注意力图揭示不同损伤模式。
要点
- 临床/MRI算法在验证队列中敏感性96%、特异性56%,深度学习模型特异性更高。
- 两模型联合将诊断准确率提升至86%,提示互补价值。
- 注意力图显示胼胝体等区域提示RRMS,脑干等区域提示MOGAD。
核心结论
- 临床/MRI算法与基于MRI的深度学习模型均能有效区分RRMS与MOGAD,联合使用提高诊断准确性。
研究设计与样本
- 多中心回顾性横断面MAGNIMS研究,纳入19个中心的406例成人非急性期MS和MOGAD的MRI扫描。
主要发现
- 临床/MRI算法在验证队列预测RRMS的准确性75%、敏感性96%、特异性56%。
- 深度学习模型在训练/测试队列准确性77%、敏感性73%、特异性83%,验证队列准确性70%、敏感性67%、特异性73%。
- 联合分类器准确性86%、敏感性84%、特异性89%。
- 概率注意力图识别RRMS相关区域体积:胼胝体1872 mm3、左侧中央前回341 mm3、右侧丘脑193 mm3、右侧扣带回皮层186 mm3。
- 概率注意力图识别MOGAD相关区域体积:脑干629 mm3、海马234 mm3、海马旁回147 mm3。
关键数值与推荐
- 临床/MRI算法在验证队列敏感性96%(95% CI 88-99)、特异性56%(95% CI 44-68)。
- 深度学习模型在验证队列准确性70%(95% CI 63-77)、敏感性67%(95% CI 55-79)、特异性73%(95% CI 61-83)。
- 联合分类器准确性86%(95% CI 81-92)、敏感性84%(95% CI 75-92)、特异性89%(95% CI 81-96)。
临床怎么用
- 临床可联合使用临床/MRI算法和深度学习模型,以提高RRMS与MOGAD的鉴别准确性。
局限性
- 回顾性横断面设计,需未来前瞻性研究在多样化的真实世界环境中验证模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Multiple sclerosis (MS) is common in adults while myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is rare. Our previous machine-learning algorithm, using clinical variables, ≤6 brain lesions, and no Dawson fingers, achieved 79% accuracy, 78% sensitivity, and 80% specificity in distinguishing MOGAD from MS but lacked validation. The aim of this study was to (1) evaluate the clinical/MRI algorithm for distinguishing MS from MOGAD, (2) develop a deep learning (DL) model, (3) assess the benefit of combining both, and (4) identify key differentiators using probability attention maps (PAMs). METHODS: This multicenter, retrospective, cross-sectional MAGNIMS study included scans from 19 centers. Inclusion criteria were as follows: adults with non-acute MS and MOGAD, with high-quality T2-fluid-attenuated inversion recovery and T1-weighted scans. Brain scans were scored by 2 readers to assess the performance of the clinical/MRI algorithm on the validation data set. A DL-based classifier using a ResNet-10 convolutional neural network was developed and tested on an independent validation data set. PAMs were generated by averaging correctly classified attention maps from both groups, identifying key differentiating regions. RESULTS: We included 406 MRI scans (218 with relapsing remitting MS [RRMS], mean age: 39 years ±11, 69% F; 188 with MOGAD, age: 41 years ±14, 61% F), split into 2 data sets: a training/testing set (n = 265: 150 with RRMS, age: 39 years ±10, 72% F; 115 with MOGAD, age: 42 years ±13, 61% F) and an independent validation set (n = 141: 68 with RRMS, age: 40 years ±14, 65% F; 73 with MOGAD, age: 40 years ±15, 63% F). The clinical/MRI algorithm predicted RRMS over MOGAD with 75% accuracy (95% CI 67-82), 96% sensitivity (95% CI 88-99), and specificity 56% (95% CI 44-68) in the validation cohort. The DL model achieved 77% accuracy (95% CI 64-89), 73% sensitivity (95% CI 57-89), and 83% specificity (95% CI 65-96) in the training/testing cohort, and 70% accuracy (95% CI 63-77), 67% sensitivity (95% CI 55-79), and 73% specificity (95% CI 61-83) in the validation cohort without retraining. When combined, the classifiers reached 86% accuracy (95% CI 81-92), 84% sensitivity (95% CI 75-92), and 89% specificity (95% CI 81-96). PAMs identified key region volumes: corpus callosum (1872 mm3), left precentral gyrus (341 mm3), right thalamus (193 mm3), and right cingulate cortex (186 mm3) for identifying RRMS and brainstem (629 mm3), hippocampus (234 mm3), and parahippocampal gyrus (147 mm3) for identifying MOGAD. DISCUSSION: Both classifiers effectively distinguished RRMS from MOGAD. The clinical/MRI model showed higher sensitivity while the DL model offered higher specificity, suggesting complementary roles. Their combination improved diagnostic accuracy, and PAMs revealed distinct damage patterns. Future prospective studies should validate these models in diverse, real-world settings. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that both a clinical/MRI algorithm and an MRI-based DL model accurately distinguish RRMS from MOGAD.
引用
- Cortese R, Sforazzini F, Gentile G, et al. Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease. Neurology. 2025. PMID: 40906978. doi:10.1212/WNL.0000000000214075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。